Analysts: CBS Dominates Ratings and 3 More Research Notes to Read Through

CBS (NYSE:CBS): Benchmark Co. raised its price target for CBS to $63 from $50, citing the company’s ratings dominance and expanded repurchase program. The firm keeps a Buy rating on the stock.

CBS 20130807

Zillow (NASDAQ:Z): Benchmark Co. raised its price target for Zillow to $105 from $75, pointing to the company’s accelerated traffic growth in the second quarter and a clearer path to monetization behind its decision. The firm keeps a Buy rating on the stock.

Z 20130807

Mead Johnson (NYSE:MJN): Credit Suisse expects Mead Johnson to benefit from a competitor recall in China and for improved top-line results to offset recent price cuts. The firm upgraded shares to Outperform from Neutral and raised its price target to $90 from $76.

MJN 20130807

Jazz Pharmaceuticals (NASDAQ:JAZZ): Following Jazz’s report of in-line revenue but lower than expected earnings per share, Cantor notes that the company’s revenue is growing at a nearly a 70 percent clip. The firm thinks the stock can advance further, and it keeps a Buy rating on the shares.

JAZZ 20130807

Don’t Miss: There’s No Magic in Disney’s Third-Quarter Earnings.

More Articles About:   , , ,  

More from The Cheat Sheet